… prognostic and or predictive value of these specific markers in the metastatic and or recurrent
cervical cancer … metastatic or recurrent cervical cancer patients treated with cisplatin-based …

… Our prognostic model composed of 3 clinical variables might … recurrent cervical cancer that
has previously been treated with radiosensitizing cisplatin or platinum-based chemotherapy …

… or recurrent cancer of the uterine cervix and our results support that extreme age is a poor
predictor for survival for women treated … chemotherapy in order to define prognostic factors for …

… The effectiveness of platinum-based chemotherapy has been reported to be … prognostic
factor in the setting of chemotherapy alone for metastatic or recurrent cervical cancer patients. On …

… prognostic role of several clinical variables in patients with recurrent and metastatic cervical
carcinoma treated with platinum-based … in our patients with recurrent cervical cancer. Earlier …

… Several prognostic factors for recurrence and survival … platinum-based chemotherapy to
disease recurrence, is recognized as a major prognostic factor for patients with ovarian cancer [7,…

… The response to NACT is reported as one of the most vital prognostic factors for patients … ,
and the response was an independent prognostic predictor, with an hazard ratio (HR) of 6.963. …

… Palliative platinum-based chemotherapy (CT) is the standard first-line treatment for
metastatic/recurrent cervical cancer. The prognosis remains poor and effective second line options …

… tumor response and survival in patients with recurrent or metastatic cervical cancer treated
via platinum-based … with resistance to platinum-based chemotherapy and poor prognosis in …

… to identify factors independently prognostic predictive of … for the treatment of women with
recurrent/metastatic cervical cancer. … whites when treated with platinum-based chemotherapy. …